Clinical Trials Browser

Phase 1 × quizartinib × Other solid neoplasm × Clear all

NCT01049893 2019-02-12

Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors